Automated microbiology is the advanced microbiology technique that allows microbiologists to perform microbiology testing more quickly and accurately. Automated microbiology technique is an improved method for isolation, early detection, enumeration and characterization of micro organism and their products in clinical, food and environment industries.
Automated microbiology techniques provide variety of experimental approaches such as sequencing and synthesis to modify or mimic a biological system. The main objective for using automated microbiology technologies is to develop and understand human diseases such as genetic diseases, cancer and identifies new molecular targets for drug discovery. In addition, the advancement in automated microbiology technique lowers the turnaround time, enhance quality control and boosts the accuracy of microbial experiments.
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4317
The market of automated microbiology is majorly driven by technological advancements that have made microbial tests faster and more accurate. For example, in February 2012, BioControl Systems introduced Non-O157 Shiga Toxigenic E.coli (STEC) test. This test provides advancement in food microbiology and molecular technology for the detection of non-O157 serotype of E.coli.
In addition, bioMeriux offers BacT/ALERT 3D microbial detection system. The system that provides high advantages such as easy access system and early detection as compared to other commercially available microbial detection system. Thus, these types of innovative introductions attract new end users (i.e. clinical laborites and biotechnologies) hence drive the market growth. In addition, wide application areas of microbial products in the energy, healthcare and environment further stimulates the uptake of automated microbiology techniques hence drives the market growth. However, stringent regulatory requirements for the use of microbiology products restrain the market growth. In addition, high cost of automated microbiology testing further restrains the market growth of automated microbiology to some extent.
Geographically, North America dominates the global automated microbiology market. The growth is mainly attributed to the presence of large number of key players that offers broad portfolio of automated microbiology. Europe is considered as the second largest region for automated microbiology market. Introduction of advancements in molecular diagnostic such as genetic probe test and others will augment the market growth in European region. In addition, positive initiatives by governments are expected to increase the number of end users of this market hence drives the market growth. For example, Abbott Laboratories received CE Marking approval in the European Union to market PLEX-ID instruments in March 2012.
This instrument is featured with molecular diagnostic technology which enables to detect and identify broad range of microbes. Thus, this factor would in turn establish healthy platform to develop the market in European region hence drives the market growth. In addition, India, South East Asia and China are considered as the emerging markets for automated microbiology because of increasing demand of this techniques coupled with rising investments by Asia Pacific governments to improve healthcare infrastructure.
Some of the key players contributing to automated microbiology market comprise Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Beckman Coulter, bioMeriux, Inc., Bio-Rad Laboratories, Inc. and others.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.